Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ridaforolimus in Advanced Sarcoma
NCT00093080Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2004
- Primary completion
- Nov 2008
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 2 trial of ridaforolimus in sarcoma, osteosarcoma (OS), leiomyosarcoma (LMS), Liposarcoma, Ewing sarcoma, sponsored by Merck & Co.. Started Oct 2004; status: completed.
02
Drugs
ridaforolimus
03
Conditions
sarcomaosteosarcoma (OS)leiomyosarcoma (LMS)LiposarcomaEwing sarcoma
Beyond the preview
Go deeper on NCT00093080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093080.